Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global neurotech devices market 3600 synopsis, 2018 - 2032
2.1.1 Regional trends
2.1.2 Product type trends
2.1.3 Conditions trends
2.1.4 End-use trends
Chapter 3 Neurotech Devices Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Rising prevalence of neurological disorders across the globe
3.5.1.2 Technological advancements in neurotech devices
3.5.1.3 Surging number of elderly population base suffering with neurological disorders
3.5.1.4 Increasing awareness and funding in neurotech industry
3.5.2 Industry pitfalls & challenges
3.5.2.1 Lack of skilled healthcare practitioners
3.6 Growth potential analysis
3.6.1 By product type
3.6.2 By conditions
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 LivaNova PLC
4.1.2 Medtronic plc
4.1.3 Abbott Laboratories
4.1.4 Boston Scientific Corporation
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Neurotech Devices Market Size and Forecast, By Product Type, 2018-2032 (USD Million)
5.1 Key trends, by product type
5.2 Neurostimulation
5.2.1 Deep brain stimulator
5.2.2 Gastric electric stimulator
5.2.3 Spinal cord stimulator
5.2.4 Sacral nerve stimulator
5.2.5 Vagus nerve stimulator
5.2.6 Transcutaneous electrical nerve stimulation (TENS)
5.2.7 Other neurostimulations
5.3 Neuroprostheses
5.4 Neurosensing
5.5 Neurorehabilitation devices
Chapter 6 Neurotech Devices Market Size and Forecast, By Conditions, 2018-2032 (USD Million)
6.1 Key trends, by conditions
6.2 Pain management
6.3 Cognitive disorders
6.4 Epilepsy
6.5 Urinary and fecal incontinence
6.6 Hearing conditions
6.7 Parkinson's disease
6.8 Depression
6.9 Sleep disorders
6.10 Essential tremor
6.11 Other conditions
Chapter 7 Neurotech Devices Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Homecare facilities
7.5 Other end-users
Chapter 8 Neurotech Devices Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Advanced Bionics AG (Sonova)
9.3 Boston Scientific Corporation
9.4 BrainCo, Inc
9.5 Cochlear Limited
9.6 Control Bionics, Inc
9.7 LivaNova PLC
9.8 Medtronic plc
9.9 Nihon Kohden Corporation
9.10 Natus Medical Incorporated
9.11 Integra LifeSciences
9.12 Blackrock Microsystems
9.13 NeuroSigma, Inc.
9.14 NeuroVigil Inc.
9.15 Neuralink Corp.
